Clinical Trials Directory

Trials / Unknown

UnknownNCT05567822

The Impact of Esmolol Administration on Postoperative Recovery

The Effect of Intraoperative Esmolol Administration on Postoperative Recovery and Chronic Pain

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Aretaieion University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this study will be to investigate the effect of a continuous infusion of low dose esmolol on intraoperative and postoperative opioid consumption, as well as on postoperative recovery and chronic pain

Detailed description

Contemporary anaesthesiology requires the quest of ways to restrict the use of opioids, which aim at the alleviation of severe postoperative and chronic pain. This is not only due to the side effects involved but also to the epidemic dimensions their use entails. Esmolol, an extremely short-acting cardioselective antagonist of β1 adrenergic receptors, is effectively used in order to attenuate the stress response and minimize undesirable perioperative hemodynamic changes. More specifically, esmolol has been used effectively to reduce pain during induction of anesthesia with propofol and treat tachycardia and hypertension during laryngoscopy. However, recent studies also highlight a possible antinociceptive and/or analgesic effect of esmolol. Therefore, The aim of this study will be to investigate the effect of a continuous infusion of low dose esmolol on intraoperative and postoperative opioid consumption, as well as on postoperative recovery and chronic pain

Conditions

Interventions

TypeNameDescription
DRUGEsmolol HydrochlorideIn the esmolol group, patients will receive a bolus dose of esmolol followed by a continuous infusion of esmolol intraoperatively
DRUGnormal salineIn the placebo group, patients will receive a bolus dose of normal saline followed by a continuous infusion of normal saline intraoperatively

Timeline

Start date
2022-10-01
Primary completion
2024-10-01
Completion
2024-10-01
First posted
2022-10-05
Last updated
2022-10-27

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT05567822. Inclusion in this directory is not an endorsement.